David Correa
About David Correa
David Correa serves as the Director of Quality Assurance at Neurelis, Inc., where he focuses on patient safety and quality management. He has over fifteen years of experience in various sectors, including healthcare and pharmaceuticals, and has held several key positions in quality assurance throughout his career.
Current Role at Neurelis
David Correa serves as the Director of Quality Assurance at Neurelis, Inc. since 2022. In this role, he focuses on ensuring the quality and compliance of products within the organization. His responsibilities include overseeing quality assurance processes and implementing best practices to enhance patient safety.
Previous Experience at Ajinomoto Bio-Pharma Services
Before joining Neurelis, David worked at Ajinomoto Bio-Pharma Services as the Manager of Technical Quality from 2018 to 2020. During his tenure, he contributed to the quality management processes, ensuring adherence to regulatory standards in the biopharmaceutical sector.
Professional Background in Quality Assurance
David has extensive experience in quality assurance, having held various positions at Althea, CMO. His roles included Technical Quality Manager, Sr. QA Associate, and Quality Assurance Supervisor, where he focused on compliance and quality management systems. He also worked at Kiniksa Pharmaceuticals as a Senior Quality Assurance Manager from 2020 to 2022.
Educational Qualifications
David Correa studied at The George Washington University, where he earned a degree in Medical Microbiology and Bacteriology from 1998 to 2000. He furthered his education at UC San Diego, achieving a certification in Clinical Trials Administration from 2011 to 2012.
Expertise and Specializations
David possesses expertise in digital transformation within quality management systems and specializes in cGMP audits and corrective and preventive actions (CAPA). He has over fifteen years of experience across various sectors, including healthcare, government, consumer goods, medical devices, pharma, and biotech.